Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes

被引：0
|
作者：
Takashi Nishimura
Satoru Iwasa
Kengo Nagashima
Natsuko Okita
Atsuo Takashima
Yoshitaka Honma
Ken Kato
Tetsuya Hamaguchi
Yasuhide Yamada
Yasuhiro Shimada
Narikazu Boku
机构：
[1] National Cancer Center Hospital,Gastrointestinal Medical Oncology Division
[2] The Jikei University School of Medicine,Department of Gastroenterology and Hepatology
[3] Chiba University,Department of Global Clinical Research, Graduate School of Medicine
来源：
Gastric Cancer | 2017年 / 20卷
关键词：
Irinotecan; Third-line chemotherapy; Gastric cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：655 / 662
页数：7
相关论文
共 50 条
  • [1] Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes
    Nishimura, Takashi
    Iwasa, Satoru
    Nagashima, Kengo
    Okita, Natsuko
    Takashima, Atsuo
    Honma, Yoshitaka
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    Boku, Narikazu
    [J]. GASTRIC CANCER, 2017, 20 (04) : 655 - 662
  • [2] IRINOTECAN AS A THIRD-LINE TREATMENT OF ADVANCED GASTRIC CANCER AFTER FAILURE OF FLUOROPYRIMIDINE, PLATINUM, AND TAXANES
    Nishimura, Takashi
    Iwasa, Satoru
    Shoji, Hirokazu
    Okita, Natsuko
    Takashima, Atsuo
    Honma, Yoshitaka
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [3] Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
    Makiyama, Akitaka
    Arimizu, Kohei
    Hirano, Gen
    Makiyama, Chinatsu
    Matsushita, Yuzo
    Shirakawa, Tsuyoshi
    Ohmura, Hirofumi
    Komoda, Masato
    Uchino, Keita
    Inadomi, Kyoko
    Arita, Shuji
    Ariyama, Hiroshi
    Kusaba, Hitoshi
    Shinohara, Yudai
    Kuwayama, Miyuki
    Kajitani, Tatsuhiro
    Oda, Hisanobu
    Esaki, Taito
    Akashi, Koichi
    Baba, Eishi
    [J]. GASTRIC CANCER, 2018, 21 (03) : 464 - 472
  • [4] Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
    Akitaka Makiyama
    Kohei Arimizu
    Gen Hirano
    Chinatsu Makiyama
    Yuzo Matsushita
    Tsuyoshi Shirakawa
    Hirofumi Ohmura
    Masato Komoda
    Keita Uchino
    Kyoko Inadomi
    Shuji Arita
    Hiroshi Ariyama
    Hitoshi Kusaba
    Yudai Shinohara
    Miyuki Kuwayama
    Tatsuhiro Kajitani
    Hisanobu Oda
    Taito Esaki
    Koichi Akashi
    Eishi Baba
    [J]. Gastric Cancer, 2018, 21 : 464 - 472
  • [5] Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer
    Takeshi Kawakami
    Nozomu Machida
    Hirofumi Yasui
    Masahiro Kawahira
    Sadayuki Kawai
    Yosuke Kito
    Yukio Yoshida
    Satoshi Hamauchi
    Takahiro Tsushima
    Akiko Todaka
    Tomoya Yokota
    Kentaro Yamazaki
    Akira Fukutomi
    Yusuke Onozawa
    [J]. Cancer Chemotherapy and Pharmacology, 2016, 78 : 809 - 814
  • [6] Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer
    Kawakami, Takeshi
    Machida, Nozomu
    Yasui, Hirofumi
    Kawahira, Masahiro
    Kawai, Sadayuki
    Kito, Yosuke
    Yoshida, Yukio
    Hamauchi, Satoshi
    Tsushima, Takahiro
    Todaka, Akiko
    Yokota, Tomoya
    Yamazaki, Kentaro
    Fukutomi, Akira
    Onozawa, Yusuke
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (04) : 809 - 814
  • [7] Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer
    Shitara, Kohei
    Matsuo, Keitaro
    Mizota, Ayako
    Kondo, Chihiro
    Nomura, Motoo
    Takahari, Daisuke
    Yokota, Tomoya
    Ura, Takashi
    Ito, Seiji
    Sawaki, Akira
    Tajika, Masahiro
    Kawai, Hiroki
    Muro, Kei
    [J]. GASTRIC CANCER, 2011, 14 (02) : 155 - 160
  • [8] Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer
    Kohei Shitara
    Keitaro Matsuo
    Ayako Mizota
    Chihiro Kondo
    Motoo Nomura
    Daisuke Takahari
    Tomoya Yokota
    Takashi Ura
    Seiji Ito
    Akira Sawaki
    Masahiro Tajika
    Hiroki Kawai
    Kei Muro
    [J]. Gastric Cancer, 2011, 14 : 155 - 160
  • [9] Efficacy and safety of irinotecan monotherapy as third line treatment for advanced gastric cancer
    Kawakami, Takeshi
    Machida, Nozomu
    Kawahira, Masahiro
    Kawai, Sadayuki
    Kito, Yosuke
    Yoshida, Yukio
    Hamauchi, Satoshi
    Tsushima, Takahiro
    Todaka, Akiko
    Yamazaki, Kentaro
    Yokota, Tomoya
    Fukutomi, Akira
    Onozawa, Yusuke
    Yasui, Hirofumi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [10] Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan
    Kondoh, Chihiro
    Kadowaki, Shigenori
    Komori, Azusa
    Narita, Yukiya
    Taniguchi, Hiroya
    Ura, Takashi
    Ando, Masashi
    Muro, Kei
    [J]. GASTRIC CANCER, 2018, 21 (06) : 1050 - 1057
12345